Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
Condition(s):Vasculopathy, Retinal, With Cerebral Leukodystrophy; Cerebroretinal Vasculopathy, HereditaryLast Updated:November 19, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Vasculopathy, Retinal, With Cerebral Leukodystrophy; Cerebroretinal Vasculopathy, HereditaryLast Updated:November 19, 2020Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:February 7, 2017Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:May 30, 2023Recruiting
Condition(s):Acute Myeloid Leukemia; Elderly Patients; Newly DiagnosedLast Updated:December 17, 2020Unknown status
Condition(s):Acute Myeloid Leukemia; Induction ChemotherapyLast Updated:September 10, 2019Unknown status
Condition(s):Acute Myeloid Leukemia; Relapse LeukemiaLast Updated:August 20, 2019Unknown status
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:November 2, 2021Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:May 19, 2022Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:February 28, 2022Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:November 19, 2019Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.